ARG57957

anti-ACMSD antibody

anti-ACMSD antibody for Western blot and Mouse,Rat

Overview

Product Description Rabbit Polyclonal antibody recognizes ACMSD
Tested Reactivity Ms, Rat
Tested Application WB
Host Rabbit
Clonality Polyclonal
Isotype IgG
Target Name ACMSD
Antigen Species Human
Immunogen Recombinant fusion protein corresponding to aa. 1-336 of Human ACMSD (NP_612199.2).
Conjugation Un-conjugated
Alternate Names EC 4.1.1.45; Picolinate carboxylase; 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase

Application Instructions

Application Suggestion
Tested Application Dilution
WB1:500 - 1:2000
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.
Positive Control Mouse kidney
Observed Size 38 kDa

Properties

Form Liquid
Purification Affinity purified.
Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol.
Preservative 0.02% Sodium azide
Stabilizer 50% Glycerol
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 171385 Rat ACMSD

GeneID: 266645 Mouse ACMSD

Swiss-port # Q8R519 Mouse 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase

Swiss-port # Q8R5M5 Rat 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase

Gene Symbol ACMSD
Gene Full Name aminocarboxymuconate semialdehyde decarboxylase
Background The neuronal excitotoxin quinolinate is an intermediate in the de novo synthesis pathway of NAD from tryptophan, and has been implicated in the pathogenesis of several neurodegenerative disorders. Quinolinate is derived from alpha-amino-beta-carboxy-muconate-epsilon-semialdehyde (ACMS). ACMSD (ACMS decarboxylase; EC 4.1.1.45) can divert ACMS to a benign catabolite and thus prevent the accumulation of quinolinate from ACMS.[supplied by OMIM, Oct 2004]
Function Converts alpha-amino-beta-carboxymuconate-epsilon-semialdehyde (ACMS) to alpha-aminomuconate semialdehyde (AMS). ACMS can be converted non-enzymatically to quinolate (QA), a key precursor of NAD, and a potent endogenous excitotoxin of neuronal cells which is implicated in the pathogenesis of various neurodegenerative disorders. In the presence of ACMSD, ACMS is converted to AMS, a benign catabolite. ACMSD ultimately controls the metabolic fate of tryptophan catabolism along the kynurenine pathway. [UniProt]
Calculated MW 38 kDa

Images (1) Click the Picture to Zoom In

  • ARG57957 anti-ACMSD antibody WB image

    Western blot: 25 µg of Mouse kidney lysate stained with ARG57957 anti-ACMSD antibody at 1:1000 dilution.